Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note

Doximity (DOCS) ended the recent trading session at $58.18, demonstrating a +0.61% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.16%, and the tech-heavy Nasdaq gained 0.98%.Prior to today's trading, shares of the medical social networking site had gained 19.98% over the past month. This has outpaced the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34% in that time.The investment community will be paying close attention to the earnings performance of Doximity in its upcoming release. In that report, analysts expect Doximity to post earnings of $0.33 per share. This would mark year-over-year growth of 13.79%. Meanwhile, our latest consensus estimate is calling for revenue of $152.44 million, up 12.69% from the prior-year quarter.In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $1.14 per share and a revenue of $539.15 million, indicating changes of +20% and +13.4%, respectively, from the former year.It is also important to note the recent changes to analyst estimates for Doximity. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Doximity is currently a Zacks Rank #1 (Strong Buy).In terms of valuation, Doximity is presently being traded at a Forward P/E ratio of 50.78. This expresses a premium compared to the average Forward P/E of 16.87 of its industry.Investors should also note that DOCS has a PEG ratio of 3.54 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical Services industry currently had an average PEG ratio of 1.48 as of yesterday's close.The Medical Services industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 130, positioning it in the bottom 49% of all 250+ industries.The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Doximity, Inc. (DOCS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks